z-logo
open-access-imgOpen Access
PD09-05 PHASE 2/3 CLINICAL RESULTS OF IL-15RΑFC SUPERAGONIST N-803 WITH BCG IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) CARCINOMA IN-SITU (CIS) PATIENTS.
Author(s) -
Karim Chamie,
Sam S. Chang,
Mark L. Gonzalgo,
Eugene Kramolowski,
Sandeep Reddy,
Paul Bhar,
Patrick SoonShiong,
Chad Garner
Publication year - 2021
Publication title -
the journal of urology/the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1097/ju.0000000000001977.05
Subject(s) - medicine , bladder cancer , carcinoma in situ , oncology , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here